Shanghai, China

Hualing Xiao

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Hualing Xiao: Innovator in Pharmaceutical Development

Introduction

Hualing Xiao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid derivatives. With a total of four patents to his name, Hualing has demonstrated a commitment to advancing medical science.

Latest Patents

Hualing Xiao's latest patents include a compound known as a steroid derivative FXR agonist. This invention relates to a compound represented by a specific formula, a tautomer, or a pharmaceutically acceptable salt, with applications in preparing drugs for treating FXR-related diseases. Another notable patent is for a crystalline or amorphous form of the steroid derivative FXR agonist, which includes a preparation method and its use in creating drugs for treating or preventing various conditions associated with FXR.

Career Highlights

Hualing Xiao is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His work at this esteemed company has allowed him to focus on innovative pharmaceutical solutions that address critical health issues. His expertise in the field has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Hualing has collaborated with notable colleagues, including Haiying He and Peng Li. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Hualing Xiao's contributions to pharmaceutical innovation, particularly in the area of FXR agonists, highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in drug development and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…